Physician profile

Boris Bagdasarian

Hematology & Oncology · Glendale, CA

NPI 1598758062

$37,768.53

in general payments reported to CMS, 2019-2025

97 companies · $7,192 in 2025

The $7,192 reported for 2025 was more than what 85% of Hematology & Oncology providers received nationally (typical 2025 total: $686).

See the full distribution for Hematology & Oncology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$16,595.00
Long Term Medical Supply Or Device Loan$1,446.39
Education$1,122.50

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $3,210.28 2019-2025
Astrazeneca Pharmaceuticals LP $2,336.04 2019-2025 Enhertu, Tagrisso, Imfinzi
Pfizer INC. $1,812.53 2019-2025
Janssen Biotech, INC. $1,724.41 2019-2025 Erleada, Rybrevant, Darzalex
Incyte Corporation $1,609.08 2019-2025 Jakafi, Monjuvi, Niktimvo
E.R. Squibb & Sons, L.L.C. $1,598.50 2019-2025 Opdivo, Opdualag, Orencia
Merck Sharp & Dohme LLC $1,578.93 2019-2025 Keytruda, Lynparza, Welireg
Celgene Corporation $1,467.52 2019-2025 Reblozyl, Pomalyst, Opdualag
Puma Biotechnology, INC. $1,454.93 2019-2024 Nerlynx
Genzyme Corporation $1,323.59 2019-2025
Amgen INC. $1,262.71 2019-2025 Lumakras, Imdelltra (Amg757)
Genentech USA, INC. $1,248.65 2019-2025 Venclexta, Phesgo, Polivy
Astellas Pharma US INC $1,128.41 2019-2025 Xospata, Xtandi, Vyloy
Bayer Healthcare Pharmaceuticals INC. $982.11 2019-2025
Seagen INC. $929.31 2020-2025 Adcetris, Padcev, Tivdak
Show all 97 companies
CompanyGeneral paymentsYearsTop products
Takeda Pharmaceuticals U.S.A., INC. $849.54 2019-2025 Iclusig, Fruzaqla, Ninlaro
Eisai INC. $766.56 2020-2025
Lilly USA, LLC $714.27 2019-2025 Verzenio, Jaypirca, Retevmo
Exelixis INC. $709.94 2020-2025 Cabometyx
Karyopharm Therapeutics INC. $695.30 2020-2025 Xpovio
Blueprint Medicines Corporation $572.66 2020-2025 Ayvakit
Gilead Sciences, INC. $516.29 2019-2025 Trodelvy
Alexion Pharmaceuticals, INC. $493.02 2019-2025 Ultomiris
Boehringer Ingelheim Pharmaceuticals, INC. $486.33 2019-2025 Gilotrif
Tersera Therapeutics LLC $484.82 2020-2025 Zoladex, Xermelo, Quzyttir
Abbvie INC. $474.97 2019-2025
Regeneron Healthcare Solutions, INC. $399.54 2020-2025 Libtayo, Lynozyfic
Array Biopharma INC $381.42 2020-2025 Braftovi, Mektovi, Lorbrena
Daiichi Sankyo INC. $337.84 2019-2025 Enhertu
Emd Serono, INC. $308.96 2019-2025 Bavencio
Kite Pharma, INC. $306.58 2020-2025 Yescarta
Glaxosmithkline, LLC. $281.00 2020-2025 Ojjaara, Zejula, Jemperli
Pharmaessentia USA Corporation $262.50 2022-2025 Besremi
Pharmacyclics LLC, An Abbvie Company $232.30 2019-2022
Caris Mpi, INC. $224.76 2025 Mi Cancer Seek
Teva Pharmaceuticals USA, INC. $203.03 2019-2020
Taiho Oncology, INC. $193.26 2020-2025
Sobi, INC $186.45 2022-2025
Dova Pharmaceuticals $180.32 2019-2021
Beigene USA, INC. $167.58 2020-2024 Brukinsa
Genmab U.S., INC. $165.66 2024-2025 Epkinly
Adc Therapeutics America, INC. $146.96 2024-2025
Janssen Scientific Affairs, LLC $144.81 2023 Erleada
Tolmar Pharmaceuticals, INC. $144.72 2020-2022
Sun Pharmaceutical Industries INC. $138.07 2022-2024
Rigel Pharmaceuticals, INC. $136.80 2019-2023 Rezlidhia, Tavalisse
Stemline Therapeutics INC. $135.64 2023-2025 Orserdu
Clovis Oncology, INC. $131.21 2019-2022
Mirati Therapeutics, INC. $129.26 2023-2024 Krazati
Tesaro, INC. $119.24 2019
Deciphera Pharmaceuticals INC. $115.98 2023-2025 Qinlock, Romvimza
Coherus Oncology, INC. $114.55 2020-2025 Loqtorzi
Geron Corporation $114.43 2025 Rytelo
Kyowa Kirin, INC. $113.35 2019-2022
Immunocore Limited $107.45 2024 Kimmtrak
Beone Medicines USA, INC. $84.84 2025 Tevimbra, Brukinsa
Agios Pharmaceuticals, INC. $80.55 2020-2025 Pyrukynd
Aurobindo Pharma USA, INC. $75.52 2019
Jazz Pharmaceuticals INC. $73.94 2024-2025
Legend Biotech USA INC. $72.21 2025 Carvykti
Lexicon Pharmaceuticals, INC. $69.69 2020
Ipsen Biopharmaceuticals, INC $69.28 2021-2025 Somatuline Depot, Onivyde
Immunogen, INC. $66.74 2023 Elahere
Amag Pharmaceuticals, INC. $62.80 2020-2021
Secura Bio, INC. $61.02 2019-2021
Morphosys, US INC. $60.70 2022-2023 Monjuvi
Organon LLC $59.69 2021-2023 Ontruzant
Verastem, INC. $56.91 2019
Tempus Ai, INC $54.71 2024-2025 Xt Cdx
Syndax Pharmaceuticals, INC. $48.85 2025
Acrotech Biopharma INC. $46.82 2021-2025 Beleodaq
Novocure INC. $43.00 2019-2021
Foundation Medicine, INC. $41.83 2020-2023
Ge Healthcare $38.59 2022
Spectrum Pharmaceuticals INC. $34.87 2019-2023 Rolvedon
Chiesi USA, INC. $34.68 2022-2024 Ferriprox
Apellis Pharmaceuticals, INC. $31.76 2024 Empaveli
Octapharma USA, INC. $30.42 2023 Panzyga
Springworks Therapeutics, INC. $29.86 2024 Ogsiveo
Pharmacosmos Therapeutics INC. $28.92 2024 Monoferric
Progenics Pharmaceuticals, INC. $26.78 2025
Emmaus Medical, INC. $25.43 2021
Integra Lifesciences Corporation $25.24 2020
Servier Pharmaceuticals LLC $24.63 2025
Myriad Genetic Laboratories, INC. $24.52 2021
Acceleron Pharma, INC. $23.52 2020
Sanofi-Aventis U.S. LLC $22.99 2019
Heron Therapeutics, INC. $22.02 2019
Epizyme, INC. $20.70 2020
Aveo Pharmaceuticals, INC. $20.27 2023 Fotivda
Verity Pharmaceuticals INC. $20.04 2023 Trelstar
Sirtex Medical INC $19.32 2020
Fennec Pharmaceuticals, INC. $18.65 2024 Pedmark
Azurity Pharmaceuticals, INC. $18.45 2025 Danziten
Janssen Pharmaceuticals, INC $17.82 2019
Eusa Pharma (US) LLC $13.91 2020
Helsinn Therapeutics (U.S.), INC. $11.67 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Boris Bagdasarian

$37,768.53

in general payments reported 2019-2025

Years
2019-2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $7,192 reported for 2025 was more than what 85% of Hematology & Oncology providers received nationally (typical 2025 total: $686).

https://glasscript.com/doctor/254429/boris-bagdasarian

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.